Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients.

Rodríguez-Antolín C, Felguera-Selas L, Pernía O, Vera O, Esteban I, Losantos García I, de Castro J, Rosas-Alonso R, Ibanez de Caceres I.

Cell Biosci. 2019 Aug 7;9:63. doi: 10.1186/s13578-019-0326-7. eCollection 2019.

2.

Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia.

Rodríguez-Jiménez C, Pernía O, Mostaza J, Rodríguez-Antolín C, de Dios García-Díaz J, Alonso-Cerezo C, García-Polo I, Blanco A, Lahoz C, Arrieta F, Beltrán L, Díaz de Bustamante A, Garzón-Lorenzo L, Álvarez-Sala LA, Asenjo Á, Ibáñez de Cáceres I, Rodríguez-Nóvoa S.

Hum Mutat. 2019 Aug;40(8):1181-1190. doi: 10.1002/humu.23801. Epub 2019 Jun 18.

PMID:
31106925
3.

Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.

Moncho-Amor V, Pintado-Berninches L, Ibañez de Cáceres I, Martín-Villar E, Quintanilla M, Chakravarty P, Cortes-Sempere M, Fernández-Varas B, Rodriguez-Antolín C, de Castro J, Sastre L, Perona R.

Int J Mol Sci. 2019 Apr 25;20(8). pii: E2036. doi: 10.3390/ijms20082036.

4.

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species.

Vera-Puente O, Rodriguez-Antolin C, Salgado-Figueroa A, Michalska P, Pernia O, Reid BM, Rosas R, Garcia-Guede A, SacristÁn S, Jimenez J, Esteban-Rodriguez I, Martin ME, Sellers TA, León R, Gonzalez VM, De Castro J, Ibanez de Caceres I.

Transl Res. 2018 Oct;200:1-17. doi: 10.1016/j.trsl.2018.06.005. Epub 2018 Jun 30.

5.

An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells.

Vera O, Rodriguez-Antolin C, de Castro J, Karreth FA, Sellers TA, Ibanez de Caceres I.

Epigenetics. 2018;13(3):251-263. doi: 10.1080/15592294.2018.1436364. Epub 2018 Apr 2.

6.

High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response.

Arrizabalaga O, Moreno-Cugnon L, Auzmendi-Iriarte J, Aldaz P, Ibanez de Caceres I, Garros-Regulez L, Moncho-Amor V, Torres-Bayona S, Pernía O, Pintado-Berninches L, Carrasco-Ramirez P, Cortes-Sempere M, Rosas R, Sanchez-Gomez P, Ruiz I, Caren H, Pollard S, Garcia I, Sacido AA, Lovell-Badge R, Belda-Iniesta C, Sampron N, Perona R, Matheu A.

Oncogenesis. 2017 Dec 14;6(12):401. doi: 10.1038/s41389-017-0003-9.

7.

DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells.

Vera O, Jimenez J, Pernia O, Rodriguez-Antolin C, Rodriguez C, Sanchez Cabo F, Soto J, Rosas R, Lopez-Magallon S, Esteban Rodriguez I, Dopazo A, Rojo F, Belda C, Alvarez R, Valentin J, Benitez J, Perona R, De Castro J, Ibanez de Caceres I.

Theranostics. 2017 Sep 22;7(17):4118-4134. doi: 10.7150/thno.20112. eCollection 2017.

8.

Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis.

Martínez-Iglesias OA, Alonso-Merino E, Gómez-Rey S, Velasco-Martín JP, Martín Orozco R, Luengo E, García Martín R, Ibáñez de Cáceres I, Fernández AF, Fraga MF, González-Peramato P, Varona C, Palacios J, Regadera J, Aranda A.

Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E328-37. doi: 10.1073/pnas.1520469113. Epub 2016 Jan 4.

9.

The impact of next-generation sequencing on the DNA methylation-based translational cancer research.

Soto J, Rodriguez-Antolin C, Vallespín E, de Castro Carpeño J, Ibanez de Caceres I.

Transl Res. 2016 Mar;169:1-18.e1. doi: 10.1016/j.trsl.2015.11.003. Epub 2015 Nov 26. Review.

10.

Biomarkers of erlotinib response in non-small cell lung cancer tumors that do not harbor the more common epidermal growth factor receptor mutations.

López-Ayllón BD, de Castro-Carpeño J, Rodriguez C, Pernía O, Ibañez de Cáceres I, Belda-Iniesta C, Perona R, Sastre L.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):2888-98. eCollection 2015.

11.

Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy.

Pernía O, Belda-Iniesta C, Pulido V, Cortes-Sempere M, Rodriguez C, Vera O, Soto J, Jiménez J, Taus A, Rojo F, Arriola E, Rovira A, Albanell J, Macías MT, de Castro J, Perona R, Ibañez de Caceres I.

Epigenetics. 2014 Nov;9(11):1446-53. doi: 10.4161/15592294.2014.971626.

12.

Expression of the SERPING1 gene is not regulated by promoter hypermethylation in peripheral blood mononuclear cells from patients with hereditary angioedema due to C1-inhibitor deficiency.

López-Lera A, Pernia O, López-Trascasa M, Ibanez de Caceres I.

Orphanet J Rare Dis. 2014 Jul 22;9:103. doi: 10.1186/s13023-014-0103-y.

13.

Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations.

Lopez-Ayllon BD, Moncho-Amor V, Abarrategi A, Ibañez de Cáceres I, Castro-Carpeño J, Belda-Iniesta C, Perona R, Sastre L.

Cancer Med. 2014 Oct;3(5):1099-111. doi: 10.1002/cam4.291. Epub 2014 Jun 25.

14.

IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.

Cortés-Sempere M, de Miguel MP, Pernía O, Rodriguez C, de Castro Carpeño J, Nistal M, Conde E, López-Ríos F, Belda-Iniesta C, Perona R, Ibanez de Caceres I.

Oncogene. 2013 Mar 7;32(10):1274-83. doi: 10.1038/onc.2012.146. Epub 2012 Apr 30.

PMID:
22543588
15.

microRNAs as novel epigenetic biomarkers for human cancer.

Cortés-Sempere M, Ibáñez de Cáceres I.

Clin Transl Oncol. 2011 Jun;13(6):357-62. doi: 10.1007/s12094-011-0668-z.

PMID:
21680295
16.

Monoclonal antibodies for medical oncology: a few critical perspectives.

Belda-Iniesta C, Ibáñez de Cáceres I, de Castro J.

Clin Transl Oncol. 2011 Feb;13(2):84-7. doi: 10.1007/s12094-011-0623-z. Review.

PMID:
21324795
17.

DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer.

Moncho-Amor V, Ibañez de Cáceres I, Bandres E, Martínez-Poveda B, Orgaz JL, Sánchez-Pérez I, Zazo S, Rovira A, Albanell J, Jiménez B, Rojo F, Belda-Iniesta C, García-Foncillas J, Perona R.

Oncogene. 2011 Feb 10;30(6):668-78. doi: 10.1038/onc.2010.449. Epub 2010 Oct 4.

PMID:
20890299
18.

Global reactivation of epigenetically silenced genes in prostate cancer.

Ibragimova I, Ibáñez de Cáceres I, Hoffman AM, Potapova A, Dulaimi E, Al-Saleem T, Hudes GR, Ochs MF, Cairns P.

Cancer Prev Res (Phila). 2010 Sep;3(9):1084-92. doi: 10.1158/1940-6207.CAPR-10-0039. Epub 2010 Aug 10.

19.

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.

Ibanez de Caceres I, Cortes-Sempere M, Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguán-García C, Cejas P, López-Ríos F, Paz-Ares L, de CastroCarpeño J, Nistal M, Belda-Iniesta C, Perona R.

Oncogene. 2010 Mar 18;29(11):1681-90. doi: 10.1038/onc.2009.454. Epub 2009 Dec 21.

PMID:
20023704
20.

Molecular biology of pancreatic cancer.

Belda-Iniesta C, Ibáñez de Cáceres I, Barriuso J, de Castro Carpeño J, González Barón M, Feliú J.

Clin Transl Oncol. 2008 Sep;10(9):530-7. Review.

PMID:
18796369
21.

VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survival.

Fu J, Fong K, Bellacosa A, Ross E, Apostolou S, Bassi DE, Jin F, Zhang J, Cairns P, Ibañez de Caceres I, Braunewell KH, Klein-Szanto AJ.

PLoS One. 2008 Feb 27;3(2):e1698. doi: 10.1371/journal.pone.0001698.

22.

Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells.

Belda-Iniesta C, Perona R, Carpeño Jde C, Cejas P, Casado E, Manguan-García C, Ibanez de Caceres I, Sanchez-Perez I, Andreu FB, Ferreira JA, Aguilera A, de la Peña J, Perez-Sánchez E, Madero R, Feliu J, Sereno M, González-Barón M.

Cancer Biol Ther. 2007 Oct;6(10):1600-5. Epub 2007 Jul 12.

PMID:
17938574
23.

Methylated DNA sequences for early cancer detection, molecular classification and chemotherapy response prediction.

Ibáñez de Cáceres I, Cairns P.

Clin Transl Oncol. 2007 Jul;9(7):429-37. Review.

PMID:
17652056
24.

Identification of novel target genes by an epigenetic reactivation screen of renal cancer.

Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P.

Cancer Res. 2006 May 15;66(10):5021-8.

25.

Endotoxin administration increases hypothalamic somatostatin mRNA through nitric oxide release.

Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

Regul Pept. 2005 Jan 15;124(1-3):113-8.

PMID:
15544848
26.

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.

27.

Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients.

Ibanez de Caceres I, Battagli C, Esteller M, Herman JG, Dulaimi E, Edelson MI, Bergman C, Ehya H, Eisenberg BL, Cairns P.

Cancer Res. 2004 Sep 15;64(18):6476-81.

28.

Promoter hypermethylation profile of kidney cancer.

Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3972-9.

29.

Telomerase is frequently activated in tumors with microsatellite instability.

Ibanez de Caceres I, Frolova N, Varkonyi RJ, Dulaimi E, Meropol NJ, Broccoli D, Cairns P.

Cancer Biol Ther. 2004 Mar;3(3):289-92. Epub 2004 Mar 10.

PMID:
14726659
30.

Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.

Battagli C, Uzzo RG, Dulaimi E, Ibanez de Caceres I, Krassenstein R, Al-Saleem T, Greenberg RE, Cairns P.

Cancer Res. 2003 Dec 15;63(24):8695-9.

31.

Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats.

Ibáñez de Cáceres I, Priego T, Martín AI, Granado M, López-Calderón A, Villanúa MA.

Eur J Pharmacol. 2003 Nov 28;481(2-3):293-9.

PMID:
14642797
32.

The inhibition of inducible nitric oxide synthase reverts arthritic-induced decrease in pituitary growth hormone mRNA but not in liver insulin-like growth factor I mRNA expression.

Ibáñez de Cáceres I, Priego T, Martín AI, López-Calderón A, Villanúa MA.

J Neuroendocrinol. 2003 Dec;15(12):1178-84.

PMID:
14636180
33.

Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats.

Priego T, Granado M, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

J Endocrinol. 2003 Oct;179(1):107-17.

PMID:
14529571
34.

NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.

Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E50-6. Epub 2003 Sep 16.

35.

Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: comparison between Lewis and Wistar rats.

Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

Mol Cell Endocrinol. 2003 Jan 31;199(1-2):23-8.

PMID:
12581876
36.

Hepatic insulin-like growth factor-I binding protein 3 gene expression in rats with endotoxic shock: the role of glucocorticoids.

Priego T, Ibañez De Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

Ann N Y Acad Sci. 2002 Nov;973:88-90.

PMID:
12485840
37.

GH administration and renal IGF-I system in arthritic rats.

Ibáñez de Cáceres I, Priego T, Martín AI, López-Calderón A, Villanúa MA.

Life Sci. 2002 May 31;71(2):139-51.

PMID:
12031684
38.

Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity.

Ibáñez De Cáceres I, Holly JM, Priego T, Martín AI, López-Calderón A, Villanúa MA.

J Endocrinol. 2002 May;173(2):357-64.

PMID:
12010643
39.

Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum IGF-I and hepatic IGF-I mRNA.

Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

J Endocrinol. 2002 Mar;172(3):449-56.

PMID:
11874693
40.

The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA.

Lopez-Calderon A, Ibáñez de Caceres I, Soto L, Priego T, Martin AI, Villanua MA.

Eur J Endocrinol. 2001 May;144(5):529-34.

PMID:
11331220
41.

IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone.

Ibañez De Cáceres I, Villanúa MA, Soto L, Martin AI, López-Calderón A.

J Endocrinol. 2000 Jun;165(3):537-44.

PMID:
10828837

Supplemental Content

Loading ...
Support Center